{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreignjtnaydrijfivb2nx7ouva3a5edqnkt37vm6tohdyioqy3qkzoa",
    "uri": "at://did:plc:izotgtw5czjnuqtpcldjnkjh/app.bsky.feed.post/3mgiu6izgqlb2"
  },
  "path": "/hormone-therapy-may-supercharge-popular-weight-loss-drugs-after-menopause/",
  "publishedAt": "2026-03-07T16:43:28.000Z",
  "site": "https://scitechdaily.com",
  "tags": [
    "Health",
    "Endocrinology",
    "Mayo Clinic",
    "Menopause",
    "Obesity",
    "Semaglutide",
    "Weight Loss"
  ],
  "textContent": "A new study suggests that a common menopause treatment may influence how effectively certain weight-loss medications work. A new study led by Mayo Clinic reports that postmenopausal women who used menopausal hormone therapy lost significantly more weight while taking tirzepatide, a drug approved by the U.S. Food and Drug Administration to treat overweight and obesity. [...]",
  "title": "Hormone Therapy May Supercharge Popular Weight-Loss Drugs After Menopause"
}